1 |
Pan TL, Wang PW, Hung YC, Huang CH, Rau KM (2013). Proteomic analysis reveals tanshinone IIA enhances apoptosis of advanced cervix carcinoma CaSki cells through mitochondria intrinsic and endoplasmic reticulum stress pathways. Proteomics, 13, 3411-23.
DOI
ScienceOn
|
2 |
Parrado A, Chomienne C, Padua RA (2000). Retinoic acid receptor alpha (RAralpha) mutations in human leukemia. Leuk Lymphoma, 39, 271-82.
DOI
ScienceOn
|
3 |
Trott O, Olson AJ (2010). AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem, 31, 455-61.
|
4 |
Wang L, Zhou GB, Liu P, et al (2008). Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia. Proc Natl Acad Sci USA, 105, 4826-31.
DOI
ScienceOn
|
5 |
Xu S, Liu P (2013). Tanshinone II-A: new perspectives for old remedies. Expert Opin Ther Pat, 23, 149-53.
DOI
ScienceOn
|
6 |
Yang L, Chen J, Shi L, et al (2010). Identifying unexpected therapeutic targets via chemical-protein interactome. PLoS One, 5, 9568.
DOI
ScienceOn
|
7 |
Guo L, Lei CK, Shan M (2008). Study of growth inhibitory effect and apoptosis induced by different matches of Tanshinone IIA and Salvianolic Acid B on acute promyelocytic leukemia cells (HL-60). Zhong Yao Cai, 31, 1512-14 (in Chinese).
|
8 |
DiMauro EF, Newcomb J, Nunes JJ, et al (2006). Discovery of aminoquinazolines as potent, orally bioavailable inhibitors of Lck: synthesis, SAR, and in vivo anti-inflammatory activity. J Med Chem, 49, 5671-86.
DOI
ScienceOn
|
9 |
Zhang S (2011). Computer-aided drug discovery and development. Methods Mol Biol, 716, 23-38.
DOI
ScienceOn
|
10 |
Yang L, Luo H, Chen J, Xing Q, He L (2009). SePreSA: a server for the prediction of populations susceptible to serious adverse drug reactions implementing the methodology of a chemical-protein interactome. Nucleic Acids Res, 37, 406-12.
DOI
ScienceOn
|
11 |
Yang L, Wang KJ, Wang LS, et al (2011). Chemical-protein interactome and its application in off-target identification. Interdiscip Sci, 3, 22-30.
DOI
ScienceOn
|
12 |
Zhai XM, He SX, Ren MD, et al (2009). Effect of Tanshinone II A on expression of EGF and EGFR in hepatocellular carcinoma cell line SMMC-7721. Zhejiang Da Xue Xue Bao Yi Xue Ban, 38, 163-9 (in Chinese).
|
13 |
Zhou LH, Hu Q, Sui H, et al (2012). Tanshinone II-a inhibits angiogenesis through down regulation of COX-2 in human colorectal cancer. Asian Pac J Cancer Prev, 13, 4453-8.
과학기술학회마을
DOI
ScienceOn
|
14 |
Li X, Xu X, Wang J, et al (2012). A system-level investigation into the mechanisms of Chinese Traditional Medicine: Compound Danshen Formula for cardiovascular disease treatment. PLoS One, 7, 43918.
DOI
|
15 |
Syahdi RR, Mun'im A, Suhartanto H, Yanuar A (2012). Virtual screening of Indonesian herbal database as HIV-1 reverse transcriptase inhibitor. Bioinformation, 8, 1206-10.
DOI
ScienceOn
|
16 |
Luo H, Chen J, Shi L, et al (2011). DRAR-CPI: a server for identifying drug repositioning potential and adverse drug reactions via the chemical-protein interactome. Nucleic Acids Res, 39, 492-8.
DOI
|
17 |
Dong Y, Morris-Natschke SL, Lee KH (2011). Biosynthesis, total syntheses, and antitumor activity of tanshinones and their analogs as potential therapeutic agents. Nat Prod Rep, 28, 529-42.
DOI
ScienceOn
|
18 |
Gao S, Liu Z, Li H, et al (2012). Cardiovascular actions and therapeutic potential of tanshinone IIA. Atherosclerosis, 220, 3-10.
DOI
ScienceOn
|
19 |
Hurle MR, Yang L, Xie Q, et al (2013). Computational drug repositioning: from data to therapeutics. Clin Pharmacol Ther, 93, 335-41.
DOI
ScienceOn
|
20 |
Lin C, Wang L, Wang H, et al (2013). Tanshinone IIA inhibits breast cancer stem cells growth in vitro and in vivo through attenuation of IL-6/STAT3/NF-kB signaling pathways. J Cell Biochem, 114, 2061-70.
DOI
ScienceOn
|
21 |
Liu JJ, Lin DJ, Liu PQ, et al (2006). Induction of apoptosis and inhibition of cell adhesive and invasive effects by tanshinone IIA in acute promyelocytic leukemia cells in vitro. J Biomed Sci, 13, 813-23.
DOI
|
22 |
Liu X, Ouyang S, Yu B, et al (2010). PharmMapper server: a web server for potential drug target identification using pharmacophore mapping approach. Nucleic Acids Res, 38, 609-14.
DOI
|
23 |
Bhattacharjee B, Vijayasarathy S, Karunakar P, Chatterjee J (2012). Comparative reverse screening approach to identify potential anti-neoplastic targets of saffron functional components and binding mode. Asian Pac J Cancer Prev, 13, 5605-11.
과학기술학회마을
DOI
ScienceOn
|
24 |
Chen SJ, Ren JL (2014). Identification of a potential anticancer target of danshensu by inverse docking. Asian Pac J Cancer Prev, 15, 111-6.
과학기술학회마을
DOI
ScienceOn
|
25 |
Akagi T, Shih LY, Kato M, et al (2009). Hidden abnormalities and novel classification of t (15;17) acute promyelocytic leukemia (APL) based on genomic alterations. Blood, 113, 1741-8.
DOI
ScienceOn
|
26 |
Bhattacharjee B, Chatterjee J (2013). Identification of proapoptopic, anti-inflammatory, anti- proliferative, antiinvasive and anti-angiogenic targets of essential oils in cardamom by dual reverse virtual screening and binding pose analysis. Asian Pac J Cancer Prev, 14, 3735-42.
과학기술학회마을
DOI
ScienceOn
|
27 |
Bourguet W, Vivat V, Wurtz JM, et al (2000). Crystal structure of a heterodimeric complex of RAR and RXR ligand-binding domains. Mol Cell, 5, 289-98.
DOI
ScienceOn
|
28 |
Chen YZ, Zhi DG (2001). Ligand-protein inverse docking and its potential use in the computer search of protein targets of a small molecule. Proteins, 43, 217-26.
DOI
|
29 |
de The H, Chen Z (2010). Acute promyelocytic leukaemia: novel insights into the mechanisms of cure. Nat Rev Cancer, 10, 775-83.
DOI
ScienceOn
|
30 |
Deshmukh S, Madagi SB (2013). A chemogenomics based approach for deorphanization of testicular receptor 4: An orphan receptor of nuclear receptor superfamily. J Nat Sci Biol Med, 4, 276-81.
DOI
ScienceOn
|
31 |
Shan YF, Shen X, Xie YK, et al (2009). Inhibitory effects of tanshinone II-A on invasion and metastasis of human colon carcinoma cells. Acta Pharmacol Sin, 30, 1537-42.
DOI
ScienceOn
|
32 |
Achenbach J, Tiikkainen P, Franke L, Proschak E (2011). Computational tools for polypharmacology and repurposing. Future Med Chem, 3, 961-8.
DOI
ScienceOn
|